Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with Tuberculosis

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Frank J. Palella, Kathleen M. Delaney, Anne C. Moorman et al. · New England Journal of Medicine · 1998 · 9.5K citations

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

Annals of Internal Medicine · 1998 · 5.2K citations

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine · 1999 · 1K citations · Full text

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Catia Marzolini, Amalio Telenti, Laurent A. Décosterd et al. · AIDS · 2001 · 831 citations

Pharmacokinetics of Rifampin Under Fasting Conditions, With Food, and With Antacids

Charles A. Peloquin, Rocsanna Namdar, Michael Singleton et al. · CHEST Journal · 1999 · 177 citations

Medicine, Physiology, Clinical Pharmacology +4